Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Food Effect Projections via Physiologically Based Pharmacokinetic Modeling: Predictive Case Studies
Christophe Tistaert, Tycho Heimbach, Binfeng Xia, et al.
Journal of Pharmaceutical Sciences (2018) Vol. 108, Iss. 1, pp. 592-602
Open Access | Times Cited: 72

Showing 26-50 of 72 citing articles:

Predicting and Confirming Bioequivalence of Alpelisib Oral Granules and Tablets for Patients With PIK3CA-Related Disorders
Elise Burmeister Getz, Séverine Niglis, Athanasia Papadimitriou, et al.
AAPS PharmSciTech (2025) Vol. 26, Iss. 5
Open Access
In Vitro and In Vivo Evaluation of 3D Printed Capsules with Pressure Triggered Release Mechanism for Oral Peptide Delivery
Staffan Berg, Julius Krause, Anders Björkbom, et al.
Journal of Pharmaceutical Sciences (2020) Vol. 110, Iss. 1, pp. 228-238
Open Access | Times Cited: 28
Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An In Vivo–In Vitro–In Silico Approach
Joseph Piscitelli, Bart Hens, Irena Tomaszewska, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 5, pp. 2589-2599
Open Access | Times Cited: 10
Streamlining Food Effect Assessment — Are Repeated Food Effect Studies Needed? An IQ Analysis
Filippos Kesisoglou, Sumit Basu, Tejashree Belubbi, et al.
The AAPS Journal (2023) Vol. 25, Iss. 4
Closed Access | Times Cited: 9
Bottom-Up Physiologically Based Oral Absorption Modeling of Free Weak Base Drugs
Naoya Matsumura, Asami Ono, Yoshiyuki Akiyama, et al.
Pharmaceutics (2020) Vol. 12, Iss. 9, pp. 844-844
Open Access | Times Cited: 24
Prediction of fasted and fed bioequivalence for immediate release drug products using physiologically based biopharmaceutics modeling (PBBM)
Rebeka Jereb, Albin Kristl, Amitava Mitra
European Journal of Pharmaceutical Sciences (2020) Vol. 155, pp. 105554-105554
Closed Access | Times Cited: 24
Integration of advanced methods and models to study drug absorption and related processes: An UNGAP perspective
Clive Wilson, Leon Aarons, Patrick Augustijns, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 172, pp. 106100-106100
Open Access | Times Cited: 21
Can PBPK Modeling Streamline Food Effect Assessments?
Filippos Kesisoglou
The Journal of Clinical Pharmacology (2020) Vol. 60, Iss. S1
Closed Access | Times Cited: 21
Physiologically Based Biopharmaceutics Modeling of Food Effect for Basmisanil: A Retrospective Case Study of the Utility for Formulation Bridging
Tejashree Belubbi, Davide Bassani, Cordula Stillhart, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 191-191
Open Access | Times Cited: 7
Multiscale modelling of drug mechanism and safety
Jitao David Zhang, Lisa Sach-Peltason, Christian Krämer, et al.
Drug Discovery Today (2019) Vol. 25, Iss. 3, pp. 519-534
Open Access | Times Cited: 21
Evaluating Utilization of Tiny-TIM to Assess the Effect of Food on the Absorptions of Oral Drugs and Its Application on Biopharmaceutical Modeling
Jia Liu, Karthik Nagapudi, Po‐Chang Chiang
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 6, pp. 1586-1596
Closed Access | Times Cited: 2
Strategy to Improve the Oral Pharmacokinetics of Cyclin-Dependent Kinase 4/6 Inhibitors: Enhancing Permeability and CYP450 Inhibition by a Natural Bioenhancer
Prajakta Patil, Mrunal Desai, Rajat Radhakrishna Rao, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 6
Open Access | Times Cited: 2
Physiologically Based Pharmacokinetic Modeling of Oral Absorption, pH, and Food Effect in Healthy Volunteers to Drive Alpelisib Formulation Selection
M Gajewska, Lars Blumenstein, Alexandros Kourentas, et al.
The AAPS Journal (2020) Vol. 22, Iss. 6
Closed Access | Times Cited: 17
In Silico Modeling and Simulation to Guide Bioequivalence Testing for Oral Drugs in a Virtual Population
Fan Zhang, Ranran Jia, Huitao Gao, et al.
Clinical Pharmacokinetics (2021) Vol. 60, Iss. 11, pp. 1373-1385
Closed Access | Times Cited: 15
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Support Waivers of In Vivo Clinical Studies: Current Status, Challenges, and Opportunities
Ioannis Loisios-Konstantinidis, Jennifer B. Dressman
Molecular Pharmaceutics (2020) Vol. 18, Iss. 1, pp. 1-17
Closed Access | Times Cited: 16
An IQ Consortium Perspective on Connecting Dissolution Methods to In Vivo Performance: Analysis of an Industrial Database and Case Studies to Propose a Workflow
Aktham Aburub, Yuan Chen, John Chung, et al.
The AAPS Journal (2022) Vol. 24, Iss. 3
Closed Access | Times Cited: 9
A Review of Current Methods for Food Effect Prediction During Drug Development
Tao Zhang, Emily Wells
Current Pharmacology Reports (2020) Vol. 6, Iss. 5, pp. 267-279
Closed Access | Times Cited: 14
Evaluating the Impact of Physiological Properties of the Gastrointestinal Tract On Drug In Vivo Performance Using Physiologically Based Biopharmaceutics Modeling and Virtual Clinical Trials
Rebeka Jereb, Jerneja Opara, Aleksander Bajc, et al.
Journal of Pharmaceutical Sciences (2021) Vol. 110, Iss. 8, pp. 3069-3081
Open Access | Times Cited: 12
Predicting Food Effects: Are We There Yet?
Arian Emami Riedmaier
The AAPS Journal (2022) Vol. 24, Iss. 1
Closed Access | Times Cited: 8
Usefulness of the Beagle Model in the Evaluation of Paracetamol and Ibuprofen Exposure after Oral Administration to Pediatric Populations: An Exploratory Study
Marina Statelova, René Holm, Nikoletta Fotaki, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 6, pp. 2836-2852
Closed Access | Times Cited: 4
Assessment of Drug–Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and Simulations
Dwaipayan Mukherjee, Michelle A. Collins, Douglas E. Dylla, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 8, pp. 2057-2070
Open Access | Times Cited: 4
Predicting Bile and Lipid Interaction for Drug Substances
Jonas Schlauersbach, Josef Kehrein, Simon Hanio, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 8, pp. 2868-2876
Closed Access | Times Cited: 7
Translational Modeling Strategies for Orally Administered Drug Products: Academic, Industrial and Regulatory Perspectives
Sandra Suarez‐Sharp, Anders Lindahl, Tycho Heimbach, et al.
Pharmaceutical Research (2020) Vol. 37, Iss. 6
Closed Access | Times Cited: 10
Negative Food Effect of Danirixin: Use of PBPK Modelling to Explore the Effect of Formulation and Meal Type on Clinical PK
Richard Lloyd, Martin Hingle, Jackie C. Bloomer, et al.
Pharmaceutical Research (2020) Vol. 37, Iss. 12
Closed Access | Times Cited: 10
Biliary Excretion–Mediated Food Effects and Prediction
Jingcheng Xiao, Doanh Tran, Xinyuan Zhang, et al.
The AAPS Journal (2020) Vol. 22, Iss. 6
Closed Access | Times Cited: 9

Scroll to top